The White House Office of Science & Technology Policy (OSTP) convened a listening session January 11. This webinar focused on the need for a coordinated clinical trials enterprise, one that can quickly characterize emerging viral threats and evaluate the effectiveness of vaccines, therapeutics, and other countermeasures across a diversity of trial participants. Jane Myles, vice president of clinical trial innovation at Curebase, was among the distinguished panelists. Curebase’s mission is to bring quality medical innovations to patients faster and improve human well-being through more efficient clinical studies. The company is proving that clinical research can be radically accelerated if physicians
The post PharmaMirror Q&A with Jane Myles, Vice President of Clinical Trial Innovation at Curebase appeared first on Pharma Mirror Magazine.
